Czechia· CZ-0290518

MCOMBRIAX

A viral vaccines product containing influenza virus a/wisconsin (h1n1) + influenza virus a/darwin (h3n2) + influenza virus b/austria (split) + sars-cov-2 (omicron xbb.1.5) spike protein (nvx-cov2601), registered in Czechia by MODERNA BIOTECH SPAIN, S.L., Madrid. The same ATC class is registered in 3 of our 19 countries.

ATC J07B

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedMCOMBRIAXATCJ07BREGISTER NO.CZ-0290518PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Influenza virus a/wisconsin (h1n1) + influenza virus a/darwin (h3n2) + influenza virus b/austria (split) + sars-cov-2 (omicron xbb.1.5) spike protein (nvx-cov2601) is registered in 3 of 19 countries.

Countries holding a registration under ATC J07B (viral vaccines), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 2 of them publish a price we can compare per daily dose

Influenza virus a/wisconsin (h1n1) + influenza virus a/darwin (h3n2) + influenza virus b/austria (split) + sars-cov-2 (omicron xbb.1.5) spike protein (nvx-cov2601) · ATC J07B

3 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Ireland
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
INFLUENZA VIRUS A/WISCONSIN (H1N1) + INFLUENZA VIRUS A/DARWIN (H3N2) + INFLUENZA VIRUS B/AUSTRIA (SPLIT) + SARS-COV-2 (OMICRON XBB.1.5) SPIKE PROTEIN (NVX-COV2601)
Manufacturer
MODERNA BIOTECH SPAIN, S.L., Madrid
Country
Czechia (CZ)
ATC code
J07B
ATC class
VIRAL VACCINES
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0093763c-ce61-45c4-b76b-048b166271b1
GET /v1/drugs/0093763c-ce61-45c4-b76b-048b166271b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ DIS ISP",
  "source": "sukl",
  "strength": null,
  "pack_size": "10X0,32ML",
  "substance": "INFLUENZA VIRUS A/WISCONSIN (H1N1) + INFLUENZA VIRUS A/DARWIN (H3N2) + INFLUENZA VIRUS B/AUSTRIA (SPLIT) + SARS-COV-2 (OMICRON XBB.1.5) SPIKE PROTEIN (NVX-COV2601)",
  "cz_kod_sukl": "0290518",
  "product_type": "IM/BT",
  "substance_codes": "1187,2625,2565,3349",
  "registration_state": "R",
  "registration_number": "EU/1/26/2028/002"
}

See everything about influenza virus a/wisconsin (h1n1) + influenza virus a/darwin (h3n2) + influenza virus b/austria (split) + sars-cov-2 (omicron xbb.1.5) spike protein (nvx-cov2601).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.